Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Last Price  /  Updated: 4:00 PM EDT, Sep 30, 2013  /  Add to My Watchlist      
(WCRX) Community Analysis from
April 19, 2014
(Stock Blog Hub, 8/19/13)
Actavis, Inc. (ACT) recently announced its intention to acquire Warner Chilcott plc (WCRX) in a stock-for-stock transaction worth about $8.5 billion. This includes the assumption of Warner...(read more)
(Stock Blog Hub, 4/23/13)
Warner Chilcott plc (WCRX) recently received encouraging news from the US Food and Drug Administration (FDA) when the regulatory agency approved the...(read more)
Warner Chilcott Plc (WCRX) is a $16.17 billion market cap company that trades an average of 1.74 million shares per day. Analysts are expecting an improvement of $0.07 in earnings per share compared to last quarter's results of $0.82. The company was founded in [...]
Warner Chilcott (WCRX) Company Overview

There is no analysis for WCRX yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here